Brown Advisory’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,811,136
| Closed | -$92.5M | – | 1436 |
|
|
2024
Q4 | $92.5M | Sell |
1,811,136
-14,626
| -0.8% | -$747K | 0.12% | 136 |
|
|
2024
Q3 | $75.3M | Buy |
1,825,762
+14,810
| +0.8% | +$611K | 0.09% | 164 |
|
|
2024
Q2 | $87.2M | Sell |
1,810,952
-12,814
| -0.7% | -$617K | 0.11% | 138 |
|
|
2024
Q1 | $87.5M | Buy |
1,823,766
+121,653
| +7% | +$5.84M | 0.12% | 149 |
|
|
2023
Q4 | $111M | Buy |
1,702,113
+255,182
| +18% | +$16.6M | 0.16% | 117 |
|
|
2023
Q3 | $94.6M | Buy |
1,446,931
+43,657
| +3% | +$2.86M | 0.16% | 121 |
|
|
2023
Q2 | $81.6M | Buy |
1,403,274
+95,754
| +7% | +$5.57M | 0.13% | 144 |
|
|
2023
Q1 | $80.7M | Buy |
1,307,520
+117,084
| +10% | +$7.23M | 0.14% | 141 |
|
|
2022
Q4 | $75.7M | Buy |
1,190,436
+88,916
| +8% | +$5.65M | 0.14% | 143 |
|
|
2022
Q3 | $80M | Sell |
1,101,520
-17,755
| -2% | -$1.29M | 0.16% | 121 |
|
|
2022
Q2 | $76.1M | Buy |
1,119,275
+399,724
| +56% | +$27.2M | 0.14% | 135 |
|
|
2022
Q1 | $65.2M | Buy |
719,551
+106,489
| +17% | +$9.65M | 0.1% | 169 |
|
|
2021
Q4 | $56M | Buy |
613,062
+97,032
| +19% | +$8.86M | 0.07% | 202 |
|
|
2021
Q3 | $41.9M | Buy |
516,030
+45,337
| +10% | +$3.68M | 0.06% | 214 |
|
|
2021
Q2 | $43.9M | Buy |
470,693
+45,943
| +11% | +$4.29M | 0.07% | 210 |
|
|
2021
Q1 | $45.4M | Buy |
424,750
+7,553
| +2% | +$808K | 0.08% | 189 |
|
|
2020
Q4 | $36.4M | Buy |
417,197
+49,964
| +14% | +$4.36M | 0.06% | 203 |
|
|
2020
Q3 | $25.3M | Buy |
367,233
+10,537
| +3% | +$727K | 0.05% | 217 |
|
|
2020
Q2 | $17.3M | Buy |
+356,696
| New | +$17.3M | 0.04% | 238 |
|